This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_STOMACH_ADENO_EXALLC for full statistics.
Adenocarcinoma and papillary adenocarcinoma of stomach
C3_STOMACH_ADENO
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
1061 |
4. Check minimum number of eventsNone |
1061 |
5. Include endpointsNone |
1061 |
6. Filter based on genotype QC (FinnGen only) |
1061 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Adenocarcinoma and papillary adenocarcinoma of stomach
based on the number of shared cases.
Similar with more cases:
- Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of stomach
- Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of digestive organs
- Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1061 | 305 | 756 |
| Unadjusted period prevalence (%) | 0.27 | 0.10 | 0.33 |
| Median age at first event (years) | 67.71 | 65.08 | 68.77 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 998
- Matched controls
- 9978
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
130
Kela drug reimbursment
Malignant tumour
24.7
323.0
570
510
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
300.5
323.0
376
20
8140/3-C16.9
ICD-O-3
Adenocarcinoma, NOS, of stomach, NOS
+∞
306.5
278
*
8140/3-C16.0
ICD-O-3
Adenocarcinoma, NOS, of cardia, NOS
+∞
279.7
255
*
107
Kela drug reimbursment
Pernicious anaemia
43.5
248.4
310
102
JDD00
NOMESCO Finland
Total gastrectomy and Roux-en-Y oesophagojejunostomy
388.2
244.7
237
8
8145/3-C16.9
ICD-O-3
Carcinoma, diffuse type of stomach, NOS
+∞
225.8
208
*
A03FA01
ATC
metoclopramide; systemic, rectal
9.8
218.8
562
1155
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
8.9
216.4
678
1916
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
89.1
207.8
228
33
B03BA03
ATC
hydroxocobalamin; parenteral
14.9
205.1
374
385
L01BC06
ATC
capecitabine; oral
29.9
200.8
276
126
C16.00
ICD-10 Finland
Cardia
382.5
190.4
186
6
A04AA02
ATC
granisetron; systemic, transdermal
16.1
157.7
270
224
H02AB02
ATC
dexamethasone; systemic
10.4
157.0
344
480
C16.09
ICD-10 Finland
Malignant tumor of cardiac or other unspecified carcinoma
542.7
145.3
141
*
C16.0
ICD-10 Finland
Malignant neoplasm: Cardia
398.3
141.6
139
*
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
65.0
137.8
159
29
C16.23
ICD-10 Finland
Malignant tumor of the corpus ventriculi diffuse carcinoma
743.4
135.0
130
*
C16.2
ICD-10 Finland
Malignant neoplasm: Body of stomach
345.9
122.1
121
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
15.8
119.6
204
160
C16.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of stomach
608.0
112.2
109
*
B81
ICPC
Anaemia vit B12/folate deficiency
13.1
109.7
203
190
D37.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Stomach
64.7
103.9
120
21
WX302
NOMESCO Finland
Thoracal epidural anesthesy
10.4
95.1
198
231
C16.20
ICD-10 Finland
Malignant tumor of the corpus ventriculi without histology
178.7
94.0
97
6
C16.3
ICD-10 Finland
Malignant neoplasm: Pyloric antrum
+∞
90.0
85
*
C16.03
ICD-10 Finland
Malignant tumor of cardiac diffuse carcinoma
478.7
89.7
88
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
39.6
89.3
113
32
C16.33
ICD-10 Finland
Malignant tumor of the antrum ventriculi diffuse carcinoma
442.8
83.3
82
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
13.1
83.0
152
135
C16.39
ICD-10 Finland
Malignant tumor of the antrum ventriculi other or unspecified carcinoma
154.6
81.4
85
6
C16.30
ICD-10 Finland
Malignant tumor of the antrum ventriculi without histology
214.1
77.4
79
*
C16.29
ICD-10 Finland
Malignant tumor of the corpus ventriculi other or unspecified carcinoma
211.1
76.3
78
*
JCF12
NOMESCO Finland
Endoscopic insertion of prosthetic tube into oesphagus
57.3
75.6
89
17
Z51.5
ICD-10 Finland
Palliative care
6.8
74.8
205
363
JCC12
NOMESCO Finland
Thoracoscopic or laparoscopic partial oesophagectomy
108.5
74.1
80
8
R4190
NOMESCO Finland
Nutritional therapy
13.8
72.6
129
106
JN4BD
NOMESCO Finland
Extensive body CT
5.3
70.8
247
587
N02AA05
ATC
oxycodone; systemic
4.1
68.5
322
1032
A04AA01
ATC
ondansetron; systemic, rectal
7.7
66.5
165
250
C16.4
ICD-10 Finland
Malignant neoplasm: Pylorus
239.0
66.0
67
*
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
18.7
60.3
94
55
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
11.1
58.2
114
114
8145/3-C16.2
ICD-O-3
Carcinoma, diffuse type of body of stomach
+∞
56.8
54
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
10.7
56.1
112
116
JAH01
NOMESCO Finland
Laparoscopy
9.9
56.0
117
132
C16.04
ICD-10 Finland
Malignant tumor of cardiac intestinal carcinoma
193.7
53.5
55
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.4
53.3
150
268
C16.01
ICD-10 Finland
Malignant tumor in cardia early diffuse gastric carcinoma early diffuse gastric carcinoma
+∞
52.6
50
*
8145/3-C16.0
ICD-O-3
Carcinoma, diffuse type of cardia, NOS
+∞
51.5
49
*
JDC20
NOMESCO Finland
Partial gastrectomy and Roux-en-Y reconstruction
116.2
51.3
55
5
C16.34
ICD-10 Finland
Malignant tumor of the antrum ventriculi intestinal carcinoma
257.2
48.5
49
*
8140/3-C16.3
ICD-O-3
Adenocarcinoma, NOS, of gastric antrum
+∞
47.3
45
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
5.4
47.1
152
320
JAH00
NOMESCO Finland
Laparotomy
9.3
45.2
97
114
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
5.7
44.9
138
273
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
7.3
43.8
110
166
8145/3-C16.3
ICD-O-3
Carcinoma, diffuse type of gastric antrum
+∞
43.0
41
*
A04AA55
ATC
palonosetron, combinations; systemic
13.9
42.5
74
57
6322
FHL
Gastrectomy (including Roux-Y)
413.3
40.4
40
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
7.4
40.3
100
148
D74
ICPC
Malignant neoplasm stomach
145.9
40.0
42
*
C16.24
ICD-10 Finland
Malignant tumor of the corpus ventriculi intestinal carcinoma
87.6
38.1
42
5
C16.21
ICD-10 Finland
Malignant tumor of the corpus ventriculi early diffuse gastric carcinoma
202.6
38.1
39
*
C15.9
ICD-10 Finland
Malignant neoplasm: Oesophagus, unspecified
30.9
37.7
50
17
178
Kela drug reimbursment
Combination product containing tegafur, gimeracil and oteracil
101.3
36.0
39
*
C16
ICD-10 Finland
Malignant neoplasm of stomach
186.4
35.0
36
*
L01BC53
ATC
tegafur, combinations; systemic
186.4
35.0
36
*
WX600
NOMESCO Finland
Single shot through catheter
17.6
34.9
55
33
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
21.4
34.7
51
25
A04AD12
ATC
aprepitant; systemic
14.7
33.7
57
41
JD1EE
NOMESCO Finland
Ultrasound examination of gastro-oesophageal reflux
175.7
32.9
34
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
7.3
32.5
80
117
JDC10
NOMESCO Finland
Partial gastrectomy and gastrojejunostomy
63.9
32.2
37
6
B01AB05
ATC
enoxaparin; parenteral
2.4
31.9
364
1933
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
18.3
31.7
49
28
JCA55
NOMESCO Finland
Endoscopic dilatation of oesophagus
15.6
31.6
52
35
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
20.5
31.6
47
24
L03AA02
ATC
filgrastim; parenteral
8.2
31.5
72
94
C16.5
ICD-10 Finland
Malignant neoplasm: Lesser curvature of stomach, unspecified
322.4
31.0
31
*
JN4CD
NOMESCO Finland
Very extensive body CT
5.4
29.6
93
187
UJD02
NOMESCO Finland
Gastroscopy
4.2
28.9
116
301
UJC12
NOMESCO Finland
Flexible oesophagoscopy
19.1
28.9
44
24
R11
ICD-10 Finland
Nausea and vomiting
3.8
28.9
130
374
C16.31
ICD-10 Finland
Malignant tumor of the antrum ventriculi early diffuse gastric carcinoma
300.2
28.9
29
*
A02BC02
ATC
pantoprazole; systemic
2.1
28.5
658
4728
8140/3-C16.2
ICD-O-3
Adenocarcinoma, NOS, of body of stomach
+∞
28.3
27
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.3
27.8
329
1754
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
10.5
27.5
54
54
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
15.3
26.7
44
30
JN4AD
NOMESCO Finland
Body CT examination
3.6
26.6
127
384
JKA20
NOMESCO Finland
Cholecystectomy
5.4
26.2
81
160
TPH07
NOMESCO Finland
Cathetrisation of artery
3.0
25.0
155
568
JDA55
NOMESCO Finland
Endoscopic dilatation of stomach, pylorus or anastomosis of stomach
39.9
25.0
31
8
WZC30
NOMESCO Finland
Teaching
2.9
24.9
165
632
JCC10
NOMESCO Finland
Transthoracic partial oesophagectomy without interposition
133.3
24.7
26
*
B03BA02
ATC
cyanocobalamin tannin complex; parenteral
19.2
24.5
37
20
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
9.8
23.2
47
50
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
7.9
22.6
52
69
A98
ICPC
Health maint/preventive medicine
0.5
22.5
535
6928
C16.02
ICD-10 Finland
Malignant tumor of cardiac early intestinal gastric carcinoma
+∞
21.9
21
*
JFF00
NOMESCO Finland
Catheter enterostomy
78.5
20.7
23
*
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
4.4
20.7
78
190
WX402
NOMESCO Finland
General anaesthesia
2.6
20.0
158
669
JDW97
NOMESCO Finland
Other laparoscopic operation on stomach or duodenum
58.7
20.0
23
*
JDD96
NOMESCO Finland
Total gastrectomy with other reconstruction
+∞
19.9
19
*
C16.6
ICD-10 Finland
Malignant neoplasm: Greater curvature of stomach, unspecified
+∞
19.9
19
*
JMA10
NOMESCO Finland
Transabdominal total splenectomy
16.8
19.7
31
19
384
Kela drug reimbursment
Combination product containing tegafur, gimeracil and oteracil
107.1
19.6
21
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
19.4
239
1263
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.3
19.4
74
183
R18
ICD-10 Finland
Ascites
7.4
19.2
46
65
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
20.5
19.1
28
14
ZX120
NOMESCO Finland
Intravenous
2.9
18.8
124
470
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.7
18.6
134
537
K92.0
ICD-10 Finland
Haematemesis
4.9
18.6
62
134
K25.9
ICD-10 Finland
Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation
5.9
18.5
52
92
K25.0
ICD-10 Finland
Gastric ulcer, Acute with haemorrhage
7.6
18.4
43
59
376
Kela drug reimbursment
Cyanocobalamin
+∞
17.8
17
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
17.4
260
1480
A06AH03
ATC
naloxegol; oral
11.4
17.3
32
29
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
8.5
17.1
37
45
K22.2
ICD-10 Finland
Oesophageal obstruction
9.3
17.0
35
39
1514C
ICD-9 Finland
Malignant neoplasm of stomach, Body of stomach[MAHASYÖPÄ, CORPORIS DIFFUUSI KARSINOOMA]
+∞
16.7
16
*
C16.19
ICD-10 Finland
Malignant tumor of the fundus ventriculi other or unspecified carcinoma
+∞
16.7
16
*
D00.2
ICD-10 Finland
Carcinoma in situ: Stomach
+∞
16.7
16
*
B01AB10
ATC
tinzaparin; parenteral
3.3
16.6
88
288
L03AA13
ATC
pegfilgrastim; parenteral
4.7
16.3
55
121
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
34.0
15.8
20
6
T91
ICPC
Vitamin/nutritional deficiency
12.0
15.6
28
24
JDC97
NOMESCO Finland
Laparoscopic partial gastrectomy with other reconstruction
162.4
15.5
16
*
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
6.7
15.5
39
60
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.7
14.6
105
419
WW500
NOMESCO Finland
Blood transfusion
3.5
14.6
69
207
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
10.3
14.5
28
28
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
8.4
14.3
31
38
R13
ICD-10 Finland
Dysphagia
2.9
14.3
92
343
JDC11
NOMESCO Finland
Laparoscopic partial gastrectomy and gastrojejunostomy
76.2
13.6
15
*
C16.32
ICD-10 Finland
Malignant tumor of the antrum ventriculi early intestinal gastric carcinoma
141.8
13.5
14
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
6.1
13.4
36
61
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
4.4
13.4
48
113
C10AA05
ATC
atorvastatin; oral
0.5
13.4
180
2879
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
14.0
13.3
22
16
K92.1
ICD-10 Finland
Melaena
2.7
13.1
92
362
K25.7
ICD-10 Finland
Gastric ulcer, Chronic without haemorrhage or perforation
7.8
12.9
29
38
JDE00
NOMESCO Finland
Gastrojejunostomy
19.3
12.9
19
10
A09AA02
ATC
multienzymes (lipase, protease etc.)
5.3
12.7
38
74
N40
ICD-10 Finland
Hyperplasia of prostate
0.5
12.6
142
2396
ZX121
NOMESCO Finland
Central venous catheter
32.5
12.6
16
5
C16.22
ICD-10 Finland
Malignant tumor of the corpus ventriculi early intestinal gastric carcinoma
+∞
12.5
12
*
I10
ICD-10 Finland
Essential (primary) hypertension
0.6
12.4
372
4918
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.1
12.2
69
235
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
4.3
12.1
44
105
D77
ICPC
Malignant digestive neopl other/NOS
27.0
12.1
16
6
8140/3-C16.4
ICD-O-3
Adenocarcinoma, NOS, of pylorus
+∞
11.5
11
*
C16.1
ICD-10 Finland
Malignant neoplasm: Fundus of stomach
121.3
11.4
12
*
C16.10
ICD-10 Finland
Malignant tumor of the fundus ventriculi without histology
121.3
11.4
12
*
C16.13
ICD-10 Finland
Malignant tumor of the fundus ventriculi diffuse carcinoma
121.3
11.4
12
*
K25.3
ICD-10 Finland
Gastric ulcer, Acute without haemorrhage or perforation
7.7
11.2
25
33
K91.1
ICD-10 Finland
Postgastric surgery syndromes
25.3
11.2
15
6
RD210
NOMESCO Finland
NA
6.2
11.1
29
48
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
11.3
11.1
20
18
TPX15
NOMESCO Finland
Removal of vascular injection port
14.1
11.0
18
13
JFF01
NOMESCO Finland
Laparoscopic catheter enterostomy
43.8
10.9
13
*
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
5.9
10.8
29
50
6321
FHL
Subtotal gastrectomy (also includes oment and spleen removal)
+∞
10.4
10
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
4.3
10.4
38
92
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
23.6
10.3
14
6
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.8
10.2
185
1109
SPAT1053
SPAT
Memory test
0.4
10.1
53
1155
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
4.9
10.1
32
67
Z98.8
ICD-10 Finland
Other specified postsurgical states
7.7
9.9
22
29
M01AH05
ATC
etoricoxib; oral
0.6
9.9
238
3358
D13.0
ICD-10 Finland
Benign neoplasm: Oesophagus
26.3
9.8
13
5
D64.9
ICD-10 Finland
Anaemia, unspecified
1.9
9.7
143
795
JFC00
NOMESCO Finland
Entero-enterostomy
55.5
9.7
11
*
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.4
9.6
43
998
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
12.5
9.4
16
13
N02AX02
ATC
tramadol; systemic, rectal
1.5
9.3
402
3044
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
5.8
9.2
25
44
B01AB04
ATC
dalteparin; parenteral
2.7
9.2
63
246
C15.2
ICD-10 Finland
Malignant neoplasm: Abdominal part of oesophagus
37.0
9.0
11
*
L03AA14
ATC
lipegfilgrastim; parenteral
5.0
8.8
27
55
JCA08
NOMESCO Finland
Endoscopic removal of foreign body from oesophagus
14.2
8.7
14
10
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
3.8
8.7
35
94
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
3.9
8.6
34
90
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
11.7
8.6
15
13
A02BC05
ATC
esomeprazole; systemic
1.5
8.6
341
2521
JK4ZT
NOMESCO Finland
Percutaneous transhepatic implantation of bile duct prothesis
27.8
8.5
11
*
C15.1
ICD-10 Finland
Malignant neoplasm: Thoracic part of oesophagus
27.8
8.5
11
*
V03AF03
ATC
calcium folinate; systemic
20.2
8.5
12
6
K25.4
ICD-10 Finland
Gastric ulcer, Chronic or unspecified with haemorrhage
5.7
8.5
23
41
15199
ICD-8 Finland
Malignant neoplasm of stomach, Part unspecified
90.8
8.4
9
*
JCC00
NOMESCO Finland
Transhiatal partial oesophagectomy without interposition
90.8
8.4
9
*
JDH35
NOMESCO Finland
Endoscopic insertion of duodenal stent
90.8
8.4
9
*
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
0.5
8.3
98
1659
8145/3-C16.4
ICD-O-3
Carcinoma, diffuse type of pylorus
+∞
8.3
8
*
C16.14
ICD-10 Finland
Malignant tumor of the fundus ventriculi intestinal carcinoma
+∞
8.3
8
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
3.0
8.3
45
153
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
7.1
8.3
19
27
A02BC03
ATC
lansoprazole; oral
1.6
8.2
282
2005
A02BX02
ATC
sucralfate; oral
2.5
8.0
62
260
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
8.0
278
1983
C09CA01
ATC
losartan; oral
0.6
7.8
96
1609
WX704
NOMESCO Finland
Intubation
2.4
7.7
65
284
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
7.5
7.7
17
23
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
4.8
7.7
24
51
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.8
7.6
125
721
6318
FHL
Resection (2/3) and gastrojejunostomy (including Roux-Y)
18.5
7.6
11
6
I50.9
ICD-10 Finland
Heart failure, unspecified
0.5
7.5
84
1444
L82
ICD-10 Finland
Seborrhoeic keratosis
0.4
7.4
39
850
C08CA01
ATC
amlodipine; oral
0.6
7.4
197
2756
Z31.5
ICD-10 Finland
Genetic counselling
3.4
7.4
33
98
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
0.6
7.3
204
2831
WB131
NOMESCO Finland
Very demanding neoadjuvant cytostatic therapy
+∞
7.3
7
*
TJF00
NOMESCO Finland
Insertion of jejunal tube
+∞
7.3
7
*
N06DA02
ATC
donepezil; oral
0.3
7.3
12
436
RD160
NOMESCO Finland
NA
15.9
7.2
11
7
R50.9
ICD-10 Finland
Fever, unspecified
1.8
7.1
129
769
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.7
7.1
46
176
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.7
6.9
132
800
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
0.5
6.9
52
1004
ZXC86
NOMESCO Finland
Use of endoscopic device
8.3
6.8
14
17
Z02.4
ICD-10 Finland
Examination for driving licence
0.6
6.8
113
1759
L01BC04
ATC
carmofur; oral
16.8
6.7
10
6
P20
ICPC
Memory disturbance
0.5
6.7
44
889
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
3.6
6.7
28
79
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
22.7
6.7
9
*
A79
ICPC
Malignancy NOS
4.5
6.7
22
50
ZX095
NOMESCO Finland
Combined chemoradiotherapy
12.3
6.6
11
9
SAA02
NOMESCO Finland
Basic examination of mouth
0.7
6.5
256
3342
M25.5
ICD-10 Finland
Pain in joint
0.6
6.5
76
1289
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
0.5
6.4
50
958
JK3NT
NOMESCO Finland
Percutaneous transhepatic dilatation of bileducts
70.3
6.4
7
*
1510E
ICD-9 Finland
Malignant neoplasm of stomach, Cardia[MAHASYÖPÄ,KARDIA,MUU TARK MÄÄR CA]
+∞
6.3
6
*
JD003
NOMESCO Finland
Adjuvant radiotherapy of gastric or duodenal tumor
+∞
6.3
6
*
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
26.8
6.2
8
*
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
26.8
6.2
8
*
N06DX01
ATC
memantine; oral
0.3
6.2
18
498
TJK00
NOMESCO Finland
Intraoperative cholangiography
7.7
6.1
13
17
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.7
6.1
167
2338
A55
ICPC
General and Unspecified, Local injection/infiltration
5.6
6.0
16
29
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
433
903
7.41
216.47
6.5
4.1
27.9
28.5
ug/l
0.02
406
768
247
327
9.54
183.34
6.0
3.3
663.9
12581.3
u/ml
0.77
231
272
173
177
11.48
154.69
4.7
3.4
153.1
2118.4
u/ml
0.77
164
166
272
764
4.44
88.91
3.3
2.2
0.2
0.2
g/l
0.02
264
704
293
1290
2.76
43.64
3.7
3.1
0.8
0.8
mmol/l
0.17
279
1191
491
6975
0.45
35.44
3.9
5.2
2.4
2.6
mmol/l
2.81
434
6253
465
6643
0.47
32.04
6.3
6.4
41.3
41.1
mmol/mol
0.21
417
6024
481
6781
0.47
31.75
3.5
4.6
4.3
4.4
mmol/l
0.92
428
6135
475
6714
0.47
31.34
3.4
4.6
1.5
1.4
mmol/l
3.00
415
6014
530
3537
2.00
26.45
10.5
4.8
32.2
34.5
g/l
16.18
514
3268
449
6289
0.50
25.65
4.2
4.4
2.0
2.2
mu/l
0.61
401
5567
472
6503
0.51
25.57
3.3
4.1
1.2
1.3
mmol/l
2.35
414
5783
398
2436
2.01
25.08
3.3
2.5
67.3
57.0
u/l
1.68
372
2242
225
1122
2.28
24.08
4.4
5.5
1.0
1.0
mmol/l
1.05
217
1029
522
6908
0.52
23.88
4.1
4.9
6.1
6.1
mmol/l
0.39
468
6131
619
7729
0.52
22.58
45.5
25.4
118.6
133.5
g/l
95.30
601
7536
619
7728
0.52
22.55
45.3
25.2
4.1
4.4
e12/l
48.97
591
7423
619
7727
0.52
22.52
45.3
25.3
264.8
236.5
e9/l
13.77
595
7454
70
207
3.55
20.16
1.7
1.4
251.6
271.7
ug/g
0.43
61
116
552
4070
1.74
17.27
15.2
6.3
11.7
12.5
umol/l
0.67
539
3846
616
7522
0.57
17.26
36.3
20.7
4.0
4.0
mmol/l
6.00
594
7269
608
7440
0.57
16.98
19.4
11.0
30.4
25.8
u/l
0.72
588
7098
616
7505
0.57
16.81
36.2
20.6
138.8
139.6
mmol/l
10.50
596
7259
364
5047
0.58
15.72
3.5
3.6
14.6
15.0
pmol/l
2.36
326
4444
259
3890
0.56
14.61
3.8
5.3
2.2
4.9
ug/l
1.70
228
3418
167
900
2.02
14.09
4.1
2.9
10.2
9.2
umol/l
0.17
150
798
141
715
2.12
14.01
5.0
2.4
37.2
33.2
u/l
0.56
130
606
227
1378
1.82
13.31
2.4
2.5
10.8
12.3
umol/l
2.06
212
1271
126
629
2.14
13.01
1.5
1.6
—
—
—
0
0
534
6582
0.62
12.93
32.9
16.5
81.7
73.4
ml/min/173m2
16.91
475
5483
198
3101
0.56
12.38
3.5
4.6
23.5
21.6
%
0.95
93
1587
227
3416
0.57
12.24
2.3
2.4
—
—
—
0
0
248
1588
1.73
11.99
7.4
3.1
2.5
2.5
mmol/l
0.41
240
1374
320
2204
1.65
11.72
2.6
2.2
3.4
3.1
mg/l
0.79
293
1855
327
2273
1.63
11.51
5.3
3.3
43.2
35.5
u/l
0.95
321
2150
203
1250
1.77
11.18
2.3
2.5
2.5
2.2
g/l
6.12
189
1149
140
777
1.92
10.73
4.3
7.0
8.2
11.5
mmol/l
5.62
130
730
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
75
330
2.37
10.47
2.1
2.4
0.4
0.4
u/ml
0.08
38
191
119
2079
0.52
10.43
2.1
2.9
3349.3
7521.4
umol/l
0.70
104
1752
419
5324
0.65
10.41
3.6
4.1
14.7
14.4
mm/h
0.14
378
4827
453
3460
1.54
10.39
5.8
4.3
—
—
—
0
0
128
2183
0.53
10.36
2.4
3.3
0.8
0.8
ug/l
0.63
95
1523
274
1869
1.63
10.22
3.5
2.5
—
—
—
0
0
362
2663
1.55
9.68
6.6
3.3
2.3
2.3
mmol/l
4.35
347
2287
188
1188
1.71
9.33
2.3
2.5
17.9
22.4
%
3.52
157
1020
611
7119
0.67
9.28
31.4
17.5
38.4
28.2
mg/l
9.73
561
5834
165
2540
0.59
9.07
3.3
4.0
13.7
9.4
mg/mmol
0.40
107
1646
515
4136
1.48
8.78
15.6
8.7
4.1
4.3
e9/l
0.44
469
3614
512
6134
0.68
8.60
34.2
18.6
35.4
38.7
%
11.97
323
3847
107
1815
0.54
8.27
1.7
1.7
1.2
1.3
mmol/l
2.21
87
1489
162
2440
0.60
7.99
2.7
3.1
8.2
7.6
mmol/l
0.99
125
1987
135
823
1.73
7.57
10.8
7.4
113.4
120.3
g/l
3.84
130
791
49
214
2.35
7.02
3.4
3.1
49.3
47.2
u/ml
0.04
49
204
45
955
0.45
6.76
1.3
1.3
81.7
15.3
u/ml
0.43
21
333
206
2830
0.66
6.47
2.8
3.2
2133.6
2059.4
ng/l
0.06
189
2454
50
944
0.51
5.37
2.9
4.7
34.8
32.0
%
1.03
36
613
488
5648
0.75
5.11
39.3
21.0
15.3
13.9
%
38.84
476
5503
183
2473
0.69
5.07
1.9
2.2
646.8
254.7
u/l
0.52
165
2304
87
526
1.71
5.05
1.7
1.4
—
—
—
0
0
148
1026
1.51
4.90
10.0
6.8
1.3
1.2
mmol/l
0.06
121
771
49
254
1.97
4.66
1.5
1.7
—
—
—
0
0
12
29
4.17
4.63
1.8
2.0
726.0
57656.4
e6/l
—
5
19
59
1012
0.56
4.62
1.3
1.3
15.9
38.8
iu/ml
4.03
16
326
146
1023
1.50
4.59
10.3
6.7
5.1
5.1
kpa
0.18
139
969
146
1024
1.49
4.57
10.3
6.7
12.7
11.6
kpa
1.85
139
972
33
153
2.19
4.21
1.7
3.9
1.7
1.6
%
0.07
26
123
359
2979
1.31
4.06
3.4
2.8
81.8
161.8
ug/l
14.74
337
2680
465
3997
1.29
4.02
9.2
6.7
1.2
1.2
mmol/l
4.85
382
3319
30
139
2.19
3.86
2.4
2.9
4.4
4.6
e9/l
0.10
30
139
109
1548
0.67
3.83
1.5
1.7
2.4
1.4
mg/l
2.37
92
1213
12
35
3.46
3.62
1.1
1.1
—
—
—
0
0
5
195
0.25
3.56
1.6
1.8
—
—
—
0
0
98
672
1.50
3.44
4.9
3.8
1.2
1.2
mmol/l
0.55
88
587
30
146
2.09
3.44
3.3
3.5
59.2
60.1
%
0.12
30
146
449
5088
0.80
3.29
4.5
4.8
8257.9
2309.9
e6/l
—
9
102
34
618
0.54
3.29
1.5
2.3
14.8
12.4
nmol/l
0.58
29
542
32
163
1.99
3.27
1.3
1.4
—
—
—
0
0
7
221
0.31
3.20
1.3
1.4
—
—
—
0
0
419
3645
1.25
3.04
8.2
6.0
1.2
1.2
mmol/l
4.45
400
3264
168
1301
1.35
3.01
2.0
2.0
31.3
30.1
s
0.61
168
1262
21
422
0.49
2.81
1.8
2.5
—
10.5
—
0
14
68
452
1.54
2.80
15.2
8.9
24.3
24.4
mmol/l
0.14
68
416
67
981
0.66
2.75
12.8
8.6
—
—
—
0
0
113
833
1.40
2.75
3.7
3.7
2.5
2.1
mmol/l
0.48
84
644
288
3346
0.81
2.44
3.7
4.2
32.1
59.6
ng/l
1.77
236
2583
5
157
0.32
2.28
1.2
1.2
20.2
39.1
u/l
—
5
134
20
377
0.52
2.25
1.0
1.4
—
48.9
—
0
20
315
3596
0.82
2.20
3.6
4.0
0.0
0.0
estimate
0.50
66
667
13
54
2.42
2.20
1.2
1.2
—
—
—
0
0
80
581
1.41
2.16
7.3
6.4
25.5
24.3
mmol/l
1.85
75
541
7
183
0.38
2.16
1.4
1.8
66.0
43.8
nmol/l
—
7
173
310
3536
0.83
2.13
5.2
5.3
0.0
0.0
estimate
0.00
67
680
56
382
1.49
2.10
5.7
4.8
1.7
1.6
%
0.52
51
357
96
1254
0.74
2.08
1.1
1.2
1.1
1.5
u/ml
0.49
31
302
313
3551
0.83
2.01
3.7
3.9
0.0
0.0
estimate
0.00
67
686
214
1815
1.22
1.87
1.9
1.8
458.0
10731797.3
pmol/l
1.06
176
1463
19
334
0.56
1.75
1.4
1.7
—
—
—
0
0
18
96
1.89
1.71
1.3
1.5
—
—
—
0
0
18
96
1.89
1.71
1.3
1.5
—
—
—
0
0
18
96
1.89
1.71
1.2
1.5
—
—
—
0
0
239
2068
1.20
1.70
1.9
1.6
21.6
19.8
nmol/l
1.20
220
1745
18
97
1.87
1.66
1.3
1.5
—
—
—
0
0
18
97
1.87
1.66
1.3
1.5
—
—
—
0
0
52
718
0.71
1.63
1.2
1.3
—
—
—
0
0
18
98
1.85
1.62
1.3
1.5
—
—
—
0
0
503
4654
1.15
1.54
7.8
4.9
6.6
6.9
mmol/l
2.49
485
4380
12
232
0.51
1.53
1.5
1.5
—
—
—
0
0
42
295
1.44
1.44
1.3
1.2
—
—
—
0
0
50
675
0.73
1.40
1.6
1.8
1.6
1.6
%
0.04
42
561
40
559
0.70
1.38
2.2
3.7
3.6
1.9
mmol/l
1.05
26
411
11
209
0.52
1.35
1.4
1.4
1.1
1.1
g/l
0.19
11
202
15
259
0.57
1.34
1.4
1.6
—
—
—
0
0
0
38
0.00
1.34
0.0
1.2
—
—
—
0
0
87
698
1.27
1.29
3.6
2.9
4.5
4.4
kpa
0.04
82
667
11
200
0.55
1.20
1.4
1.4
0.2
0.2
g/l
0.32
11
193
0
33
0.00
1.16
0.0
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
34
0.00
1.16
0.0
1.1
—
—
—
0
0
36
494
0.72
1.15
1.5
1.4
—
—
—
0
0
8
153
0.52
1.14
1.4
1.3
—
—
—
0
0
7
138
0.50
1.10
1.0
1.2
3.4
3.9
mmol/l
—
7
128
9
166
0.54
1.08
1.9
1.6
—
—
—
0
0
13
75
1.74
1.03
1.2
1.4
—
—
—
0
0
0
29
0.00
0.98
0.0
1.0
—
—
—
0
0
0
30
0.00
0.97
0.0
1.2
—
—
—
0
0
0
30
0.00
0.97
0.0
1.0
—
—
—
0
0
0
31
0.00
0.96
0.0
1.0
—
1.1
—
0
18
0
31
0.00
0.96
0.0
4.7
—
65.6
—
0
25
0
32
0.00
0.95
0.0
1.0
—
—
—
0
0
11
185
0.59
0.95
1.2
1.9
28.4
12.5
mg/l
0.42
11
167
113
1307
0.85
0.90
21.9
30.2
1.3
1.4
inr
0.83
20
183
17
111
1.54
0.88
5.3
5.7
11.7
12.3
mg/l
0.24
17
100
13
204
0.63
0.86
3.2
2.9
2.1
1.8
mg/l
0.31
13
182
253
2757
0.89
0.86
4.0
4.3
—
—
—
0
0
104
893
1.18
0.86
6.1
3.8
—
—
—
0
0
8
46
1.74
0.82
1.3
2.5
—
—
—
0
0
17
113
1.51
0.82
1.4
1.3
—
—
—
0
0
26
350
0.74
0.79
3.3
2.8
—
—
—
0
0
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
0
25
0.00
0.79
0.0
1.0
—
—
—
0
0
0
25
0.00
0.79
0.0
1.0
—
—
—
0
0
144
1609
0.88
0.74
3.8
4.3
1.0
1.0
kg/l
0.24
20
241
76
647
1.19
0.72
2.1
2.0
377.6
376.5
nmol/l
0.02
71
586
5
95
0.52
0.66
1.0
1.1
1.7
1.6
g/l
—
5
85
410
4312
0.92
0.66
3.4
3.2
77.7
57.3
u/l
1.38
381
3939
149
1345
1.13
0.65
3.2
3.2
2.3
1.6
e6/l
0.68
93
793
28
360
0.77
0.65
1.2
2.5
7.4
7.3
g/l
0.08
19
267
28
360
0.77
0.65
1.2
2.5
—
—
—
0
0
28
359
0.77
0.64
1.2
2.5
3.5
3.8
g/l
0.99
18
256
5
29
1.73
0.64
1.0
1.2
32.2
25.8
%
—
5
17
8
130
0.61
0.64
1.0
1.3
—
—
—
0
0
17
121
1.41
0.62
1.1
1.4
20943.8
83341.6
e6/l
0.65
11
71
8
49
1.64
0.62
1.0
1.6
—
90.0
u/l
—
0
10
8
50
1.60
0.61
1.8
1.8
—
—
—
0
0
26
334
0.77
0.61
1.2
2.6
3.1
3.1
g/l
0.05
18
261
9
141
0.64
0.60
1.1
1.1
—
—
—
0
0
0
21
0.00
0.60
0.0
1.0
—
1707.6
—
0
21
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
0
21
0.00
0.60
0.0
1.6
—
—
—
0
0
49
409
1.21
0.59
3.7
3.8
23.5
24.0
mmol/l
0.41
44
365
8
52
1.54
0.59
1.3
3.3
—
—
—
0
0
0
22
0.00
0.59
0.0
1.9
—
—
—
0
0
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
20
264
0.75
0.57
1.3
1.3
—
—
—
0
0
199
1841
1.10
0.57
2.0
1.8
1199.1
1180.4
nmol/l
0.10
166
1374
22
167
1.32
0.57
1.6
2.6
258.1
201.3
%
1.80
22
159
5
86
0.58
0.56
1.2
1.3
13.8
13.2
u/l
—
5
79
7
45
1.56
0.49
4.4
4.3
—
—
—
0
0
247
2327
1.08
0.48
3.1
3.4
1.2
0.6
e6/l
0.73
193
1819
8
118
0.68
0.46
1.1
1.1
—
—
—
0
0
5
83
0.60
0.45
1.0
1.4
11.2
13.9
u/l
—
5
76
593
5770
1.06
0.44
16.5
7.7
111.8
82.0
u/l
9.79
574
5360
18
230
0.78
0.44
1.1
1.0
—
—
—
0
0
26
212
1.23
0.42
1.2
3.1
30.0
35.7
umol/l
0.51
21
170
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
0
15
0.00
0.41
0.0
1.2
—
27.2
—
0
10
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
5
34
1.47
0.40
1.0
1.3
—
—
—
0
0
12
88
1.37
0.40
1.3
1.6
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
75
831
0.90
0.39
2.4
2.6
4.8
7.0
ug/l
0.87
59
714
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
328
3409
0.95
0.36
2.4
2.1
84.6
92.5
pmol/l
3.28
234
1797
6
45
1.34
0.33
1.2
1.6
—
—
—
0
0
6
45
1.34
0.33
1.2
1.6
—
—
—
0
0
25
296
0.84
0.33
1.1
1.2
115.8
159.4
iu/ml
—
6
105
7
56
1.25
0.29
1.1
1.5
—
—
—
0
0
143
1511
0.94
0.28
1.7
1.9
—
—
—
0
0
52
574
0.90
0.28
1.9
1.6
—
—
—
0
0
5
72
0.69
0.26
1.4
1.2
7.1
7.8
mmol/l
—
5
47
12
149
0.80
0.26
1.3
1.3
0.7
0.9
nmol/l
0.39
12
120
191
1989
0.95
0.24
3.3
4.2
0.0
0.0
estimate
0.50
54
650
5
38
1.32
0.23
2.0
2.9
193.8
213.5
u/l
—
5
38
15
125
1.20
0.22
1.0
1.1
—
—
—
0
0
17
199
0.85
0.21
4.1
3.8
62.3
30.0
mg/l
1.24
11
133
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
108
1024
1.06
0.21
2.2
3.9
216.0
248.5
u/l
3.35
101
968
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
2.5
—
2.3
—
0
7
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
34
375
0.90
0.19
1.8
1.9
—
—
—
0
0
15
175
0.86
0.19
1.3
1.5
—
—
—
0
0
27
242
1.12
0.18
1.3
1.6
—
—
—
0
0
8
68
1.18
0.16
1.8
1.3
—
—
—
0
0
18
204
0.88
0.16
1.2
1.6
—
—
—
0
0
31
339
0.91
0.16
1.6
1.7
—
—
—
0
0
6
78
0.77
0.15
1.3
1.7
—
—
—
0
0
6
78
0.77
0.15
1.3
1.7
—
—
—
0
0
6
78
0.77
0.15
1.3
1.7
—
—
—
0
0
6
80
0.75
0.15
1.5
1.4
—
—
—
0
0
19
212
0.89
0.14
1.2
1.6
—
—
—
0
0
8
98
0.81
0.13
1.1
1.3
—
—
—
0
0
8
98
0.81
0.13
2.4
3.6
—
—
—
0
0
56
592
0.94
0.13
5.8
3.1
59.6
60.0
ml/min/173m2
0.02
23
254
15
169
0.89
0.12
1.5
1.6
—
—
—
0
0
307
3017
1.02
0.12
3.1
3.5
—
—
—
0
0
160
1641
0.97
0.11
3.3
4.0
725.8
296.5
ng/l
0.36
132
1408
10
87
1.15
0.09
1.1
1.3
50.1
24.3
iu/l
—
10
69
13
145
0.90
0.09
1.2
1.5
—
—
—
0
0
11
124
0.89
0.09
1.1
1.1
—
—
—
0
0
104
1066
0.97
0.07
1.7
1.8
—
—
—
0
0
289
2855
1.02
0.07
2.5
2.2
73.8
77.7
nmol/l
1.58
267
2470
8
74
1.08
0.07
1.4
1.7
—
—
—
0
0
8
76
1.05
0.07
1.1
1.6
—
—
—
0
0
8
78
1.03
0.07
1.4
1.3
—
—
—
0
0
7
82
0.85
0.07
1.3
1.8
—
—
—
0
0
7
85
0.82
0.07
1.3
1.8
—
—
—
0
0
11
99
1.11
0.06
1.1
1.6
—
—
—
0
0
20
213
0.94
0.06
1.4
1.4
—
—
—
0
0
13
119
1.09
0.06
1.1
1.8
84.6
89.6
%
0.62
13
119
17
182
0.93
0.05
1.2
1.3
—
—
—
0
0
19
202
0.94
0.05
1.4
1.3
—
—
—
0
0
19
202
0.94
0.05
1.4
1.3
—
—
—
0
0
186
1837
1.02
0.05
2.3
2.7
6.2
4.2
e6/l
2.66
166
1633
104
1058
0.98
0.04
1.7
1.8
—
—
—
0
0
59
605
0.97
0.04
4.3
4.0
109.4
98.2
ng/l
0.30
49
529
14
130
1.08
0.04
2.0
2.2
32.5
32.3
pg
0.03
14
130
12
129
0.93
0.03
1.2
1.5
—
—
—
0
0
84
829
1.01
0.02
2.4
3.1
259.5
266.6
ng/l
0.05
78
754
19
198
0.96
0.02
1.2
1.2
—
—
—
0
0
11
114
0.96
0.00
1.2
1.5
—
—
—
0
0
19
194
0.98
0.00
1.9
2.2
110.5
127.9
g/l
1.56
13
143
12
118
1.02
0.00
1.2
1.5
—
—
—
0
0
20
198
1.01
0.00
1.2
1.2
—
—
—
0
0
12
121
0.99
0.00
1.2
1.6
—
—
—
0
0
12
117
1.03
0.00
1.6
2.3
360.3
41.7
u/ml
0.41
12
110
15
153
0.98
0.00
1.2
1.7
—
—
—
0
0
19
195
0.97
0.00
1.8
2.5
12.2
15.4
%
—
7
98
10
95
1.05
0.00
1.9
2.7
—
—
—
0
0
5
55
0.91
0.00
1.2
1.3
—
—
—
0
0
5
55
0.91
0.00
1.2
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
7
73
0.96
0.00
1.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
6.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
92.1
—
0
9
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
5
54
0.93
0.00
1.0
1.0
322.2
277.9
mg/l
—
5
46
0
7
0.00
0.00
0.0
4.4
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
23.3
—
0
7
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
141
1410
1.00
0.00
3.1
3.0
1.6
1.1
e6/l
1.34
85
854
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
7
73
0.96
0.00
1.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_STOMACH_ADENO – Adenocarcinoma and papillary adenocarcinoma of stomach
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).